ATE356144T1 - Regulatorische/entfaltende peptide von ezrin - Google Patents
Regulatorische/entfaltende peptide von ezrinInfo
- Publication number
- ATE356144T1 ATE356144T1 AT00962685T AT00962685T ATE356144T1 AT E356144 T1 ATE356144 T1 AT E356144T1 AT 00962685 T AT00962685 T AT 00962685T AT 00962685 T AT00962685 T AT 00962685T AT E356144 T1 ATE356144 T1 AT E356144T1
- Authority
- AT
- Austria
- Prior art keywords
- ezrin
- regulatory
- developing peptides
- peptides
- developing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9921881A GB2354241A (en) | 1999-09-17 | 1999-09-17 | Regulatory/unfolding peptides of ezrin |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE356144T1 true ATE356144T1 (de) | 2007-03-15 |
Family
ID=10861009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00962685T ATE356144T1 (de) | 1999-09-17 | 2000-09-15 | Regulatorische/entfaltende peptide von ezrin |
Country Status (23)
Country | Link |
---|---|
US (1) | US6849596B1 (de) |
EP (2) | EP1131348B1 (de) |
JP (1) | JP2003511389A (de) |
KR (1) | KR20010101017A (de) |
CN (1) | CN100387619C (de) |
AT (1) | ATE356144T1 (de) |
AU (1) | AU770208B2 (de) |
BR (1) | BR0007158A (de) |
CA (1) | CA2348780A1 (de) |
CY (1) | CY1106644T1 (de) |
CZ (1) | CZ20011689A3 (de) |
DE (1) | DE60033783T2 (de) |
DK (1) | DK1131348T3 (de) |
ES (1) | ES2283317T3 (de) |
GB (1) | GB2354241A (de) |
HU (1) | HUP0104254A3 (de) |
NO (1) | NO20012417L (de) |
NZ (1) | NZ511747A (de) |
PL (1) | PL348635A1 (de) |
PT (1) | PT1131348E (de) |
RU (1) | RU2215005C2 (de) |
WO (1) | WO2001025275A1 (de) |
ZA (1) | ZA200103938B (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0301879D0 (en) * | 2003-01-27 | 2003-02-26 | Regent Res Llp | HCV combination therapy |
WO2007060440A2 (en) * | 2005-11-23 | 2007-05-31 | Regent Research L.L.P. | The use of peptides in anti-ulcer therapy |
CN100455665C (zh) * | 2006-11-21 | 2009-01-28 | 汕头大学医学院 | 人食管癌细胞ezrin基因上游转录调控元件 |
WO2009103312A1 (en) * | 2008-02-19 | 2009-08-27 | Ludwig-Maximilians-Universität | Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases |
RU2580629C1 (ru) * | 2015-05-15 | 2016-04-10 | Федеральное государственное бюджетное учреждение "Научный центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации | Способ прогнозирования рецептивности эндометрия на основании оценки экспрессии и внутриклеточной локализации эзрина в эндометрии женщин с бесплодием и повторными неудачами программы эко |
MA39421A (fr) | 2015-06-01 | 2017-07-19 | Nearmedic International Ltd | Peptides dérivés de l'ezrine et compositions pharmaceutiques correspondantes |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2290293A (en) * | 1994-06-08 | 1995-12-20 | Rupert Donald Holms | Preparation which inhibits the autoimmune response in HIV, or SLE, patients |
EP0861323A1 (de) | 1995-10-02 | 1998-09-02 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Ein epitheliales protein und korrespondierende dna und deren verwendung in der krebsfrüherkennung |
US6399584B1 (en) * | 1998-03-18 | 2002-06-04 | Institute Curie | Pharmaceutical composition containing ezrin mutated on tyrosine 353 |
-
1999
- 1999-09-17 GB GB9921881A patent/GB2354241A/en not_active Withdrawn
-
2000
- 2000-09-15 EP EP00962685A patent/EP1131348B1/de not_active Expired - Lifetime
- 2000-09-15 US US09/856,070 patent/US6849596B1/en not_active Expired - Fee Related
- 2000-09-15 CZ CZ20011689A patent/CZ20011689A3/cs unknown
- 2000-09-15 PT PT00962685T patent/PT1131348E/pt unknown
- 2000-09-15 DK DK00962685T patent/DK1131348T3/da active
- 2000-09-15 JP JP2001528215A patent/JP2003511389A/ja not_active Withdrawn
- 2000-09-15 DE DE60033783T patent/DE60033783T2/de not_active Expired - Fee Related
- 2000-09-15 HU HU0104254A patent/HUP0104254A3/hu unknown
- 2000-09-15 BR BR0007158-7A patent/BR0007158A/pt not_active IP Right Cessation
- 2000-09-15 AT AT00962685T patent/ATE356144T1/de not_active IP Right Cessation
- 2000-09-15 AU AU74333/00A patent/AU770208B2/en not_active Ceased
- 2000-09-15 WO PCT/GB2000/003566 patent/WO2001025275A1/en active IP Right Grant
- 2000-09-15 CN CNB008022844A patent/CN100387619C/zh not_active Expired - Fee Related
- 2000-09-15 CA CA002348780A patent/CA2348780A1/en not_active Abandoned
- 2000-09-15 PL PL00348635A patent/PL348635A1/xx unknown
- 2000-09-15 NZ NZ511747A patent/NZ511747A/xx unknown
- 2000-09-15 EP EP06009089A patent/EP1760090A1/de not_active Withdrawn
- 2000-09-15 KR KR1020017006187A patent/KR20010101017A/ko not_active Application Discontinuation
- 2000-09-15 RU RU2001113277/04A patent/RU2215005C2/ru not_active IP Right Cessation
- 2000-09-15 ES ES00962685T patent/ES2283317T3/es not_active Expired - Lifetime
-
2001
- 2001-05-15 ZA ZA200103938A patent/ZA200103938B/en unknown
- 2001-05-16 NO NO20012417A patent/NO20012417L/no not_active Application Discontinuation
-
2007
- 2007-06-06 CY CY20071100749T patent/CY1106644T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1131348B1 (de) | 2007-03-07 |
ES2283317T3 (es) | 2007-11-01 |
WO2001025275A9 (en) | 2002-07-25 |
NZ511747A (en) | 2004-03-26 |
GB9921881D0 (en) | 1999-11-17 |
CN100387619C (zh) | 2008-05-14 |
WO2001025275A1 (en) | 2001-04-12 |
PL348635A1 (en) | 2002-06-03 |
DE60033783D1 (de) | 2007-04-19 |
HUP0104254A2 (hu) | 2002-04-29 |
NO20012417D0 (no) | 2001-05-16 |
CZ20011689A3 (cs) | 2001-12-12 |
HUP0104254A3 (en) | 2002-05-28 |
EP1760090A1 (de) | 2007-03-07 |
CN1327450A (zh) | 2001-12-19 |
ZA200103938B (en) | 2002-05-15 |
BR0007158A (pt) | 2001-07-31 |
GB2354241A (en) | 2001-03-21 |
US6849596B1 (en) | 2005-02-01 |
EP1131348A1 (de) | 2001-09-12 |
AU7433300A (en) | 2001-05-10 |
CA2348780A1 (en) | 2001-04-12 |
DE60033783T2 (de) | 2007-11-15 |
KR20010101017A (ko) | 2001-11-14 |
PT1131348E (pt) | 2007-11-19 |
JP2003511389A (ja) | 2003-03-25 |
AU770208B2 (en) | 2004-02-19 |
RU2215005C2 (ru) | 2003-10-27 |
DK1131348T3 (da) | 2007-07-09 |
CY1106644T1 (el) | 2012-01-25 |
NO20012417L (no) | 2001-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR12C0004I1 (de) | ||
CY1114164T1 (el) | Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου | |
NO933126D0 (no) | Loeselige ligander for cd40 | |
NO20014415D0 (no) | Medisinske preparater til behandling av <alfa>-galaktosidase- A-defisiens | |
DE60233955D1 (de) | Spezifische bindungsmittel von human angiopoietin-2 | |
NL192275B (nl) | Eiwit van het AIDS-virus. | |
ID22977A (id) | Konjugasi polietilen glikol-interferon alfa untuk terapi suatu infeksi | |
DE10299049I1 (de) | Rekombinante Viren. | |
TR200002965T2 (tr) | Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı | |
DE3888086D1 (de) | Rekombinantes Geflügelpockenvirus, Expressionsvektoren für heterologische Proteine und davon derivierte Geflügelvakzine. | |
DE3851238D1 (de) | Antikoagulierende Peptide. | |
ATE165345T1 (de) | Sulfonsaeurederivate zur behandlung von viruserkrankungen | |
TR199901949T2 (xx) | Lemfositik t�m�rler i�in �areler. | |
ATE402713T1 (de) | Genetisch manipulierte herpesviren zur behandlung von tumoren | |
DE69530844D1 (de) | Verfahren und substanzen gegen protozoen | |
DE3776999D1 (de) | Mittel zur vorbeugung gegen pflanzenviruskrankheiten. | |
NO911429L (no) | Stoffbehandling. | |
ATE356144T1 (de) | Regulatorische/entfaltende peptide von ezrin | |
ATE201693T1 (de) | Hämoregulierende peptide | |
NO913117L (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
NO911430D0 (no) | Stoffbehandlingsmetode. | |
ES2149791T3 (es) | Procedimiento para la inactivacion de virus en preparaciones de proteinas. | |
NO951679L (no) | Fibronektin-bindende protein, samt fremstilling derav | |
ATE528392T1 (de) | Neues protein und dessen dns | |
MX9203129A (es) | Proteinas bmp-5. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1131348 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |